Pulse Biosciences reported a gross margin of 37.10% and a net margin of -5,684.79% for the quarter ended Jun 2026. These financial ratios cover 41 quarters of results from Mar 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||
| Gross Margin | -26.66% | -47.04% | -104.73% | -348.00% | 14,444.44% | -224.42% | 1.52% | 37.10% | |||||||||||||||||||||||||||||||||
| EBT Margin | -2,488.15% | -1,826.54% | -3,890.32% | -4,665.33% | 102,188.89% | -22,518.60% | -6,601.52% | -5,684.79% | |||||||||||||||||||||||||||||||||
| EBIT Margin | -2,486.59% | -1,825.83% | -3,890.32% | -4,671.33% | 97,166.67% | -23,682.56% | -6,914.02% | -5,823.04% | |||||||||||||||||||||||||||||||||
| EBITDA Margin | -2,486.59% | -1,825.83% | -3,890.32% | -4,671.33% | 97,166.67% | -23,682.56% | -6,914.02% | -5,823.04% | |||||||||||||||||||||||||||||||||
| Operating Margin | -2,486.59% | -1,825.83% | -3,890.32% | -4,671.33% | 97,166.67% | -23,682.56% | -6,914.02% | -5,823.04% | |||||||||||||||||||||||||||||||||
| Net Margin | -2,488.15% | -1,826.54% | -3,890.32% | -4,665.33% | 102,188.89% | -22,518.60% | -6,601.52% | -5,684.79% | |||||||||||||||||||||||||||||||||
| FCF Margin | -2,353.14% | -1,519.91% | -3,575.00% | -4,280.33% | 88,955.56% | -15,233.72% | -5,628.79% | ||||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.91M | 3.49M | 5.05M | 6.66M | 7.68M | 4.31M | 0.04M | 0.05M | 0.10M | 0.19M | |||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 80.30M | 73.59M | 63.15M | 49.34M | 40.07M | 64.08M | 82.72M | 74.05M | 72.49M | 70.35M | 62.55M | 54.16M | 44.80M | 66.74M | 112.75M | 132.92M | 126.82M | 114.51M | 101.65M | 105.05M | |||||||||||||||||||||
| Invested CapitalInvested Cap. | 61.48M | 48.47M | 44.80M | 71.29M | 63.67M | 55.13M | 60.50M | 52.15M | 44.36M | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.05 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | ||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -28.64 | ||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.02 | 0.02 | 0.01 | 0.74 | 0.85 | 0.94 | |||||||||||||||||||||||||||||||||||
| Times Interest Earned | -28.64 | ||||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -30.65 | -44.81 | -28.55 | -8.39 | -4.06 | -4.75 | -11.21 | -12.89 | -32.29 | -20.97 | -56.56 | -47.45 | -54.29 | -85.09 | -59.21 | -64.45 | -52.96 | -61.91 | -53.44 | -79.58 | |||||||||||||||||||||
| Price to SalesP/S | 0.00M | 521.44 | 326.21 | 189.34 | -0.01M | 0.01M | 0.00M | 0.00M | |||||||||||||||||||||||||||||||||
| Price to BookP/B | 8.13 | 13.51 | 9.92 | 6.96 | 2.43 | 13.83 | -45.88 | -11.84 | 5.29 | 4.25 | 15.22 | 13.26 | 22.92 | 13.64 | 9.99 | 9.14 | 9.72 | 12.93 | 11.55 | 19.73 | |||||||||||||||||||||
| Enterprise Value | 438.11M | 598.03M | 395.73M | 132.16M | 42.00M | 16.46M | 42.00M | 72.21M | 261.29M | 171.23M | 630.60M | 446.11M | 591.81M | 999.96M | 1,029.73M | 963.16M | 908.88M | 1,103.75M | 850.70M | 1,861.66M | |||||||||||||||||||||
| EV to EBIT | -29.59 | -41.90 | -25.68 | -7.65 | -3.00 | -0.91 | -4.80 | -7.55 | -25.55 | -15.22 | -50.31 | -42.03 | -50.47 | -73.23 | -50.82 | -53.38 | -44.83 | -54.19 | -46.61 | -73.67 | |||||||||||||||||||||
| EV to EBITDA | -29.59 | -41.90 | -25.68 | -7.65 | -3.00 | -0.91 | -4.80 | -7.55 | -25.55 | -15.22 | -50.31 | -42.03 | -50.47 | -73.23 | -50.82 | -53.38 | -44.83 | -54.19 | -46.61 | -73.67 | |||||||||||||||||||||
| Market Capitalization | 485.54M | 640.03M | 440.09M | 144.84M | 56.80M | 85.62M | 103.14M | 126.31M | 320.04M | 221.61M | 674.96M | 481.01M | 618.00M | 1,078.99M | 1,147.77M | 1,082.44M | 1,015.23M | 1,198.96M | 931.44M | 1,963.28M | |||||||||||||||||||||
| Price to FCFP/FCF | -29.50 | -47.39 | -34.31 | -9.12 | -4.42 | -8.01 | -12.88 | -19.11 | -34.72 | -21.09 | -98.90 | -49.16 | -73.36 | -119.07 | -124.80 | -79.79 | -78.64 | -91.52 | -62.68 | ||||||||||||||||||||||
| EV to FCF | -26.62 | -44.28 | -30.85 | -8.33 | -3.27 | -1.54 | -5.25 | -10.93 | -28.35 | -16.29 | -92.40 | -45.59 | -70.25 | -110.35 | -111.96 | -71.00 | -70.40 | -84.25 | -57.25 | ||||||||||||||||||||||
| EV to CFO | -26.77 | -44.80 | -31.17 | -8.48 | -3.28 | -1.55 | -5.27 | -10.99 | -28.40 | -16.33 | -92.98 | -45.61 | -70.49 | -110.81 | -112.61 | -71.23 | -70.97 | -84.65 | -57.66 | ||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -2,486.59% | -1,825.83% | -3,890.32% | -4,671.33% | -4,075.69% | 97,166.67% | -17,301.03% | 517,322.22% | 442,066.67% | -23,682.56% | -6,914.02% | -5,823.04% | |||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -85.15% | -95.76% | -111.64% | -152.73% | -187.59% | -113.38% | -75.65% | -75.08% | -69.62% | -61.29% | -78.03% | -90.93% | -118.78% | -80.89% | -54.78% | -50.88% | -61.30% | -75.33% | -82.09% | -89.47% | |||||||||||||||||||||
| Return on Assets [ROA]ROA | -76.26% | -85.10% | -101.81% | -127.29% | -152.17% | -101.00% | -70.72% | -68.92% | -64.76% | -56.11% | -67.48% | -78.56% | -98.27% | -69.13% | -47.52% | -45.32% | -53.64% | -65.25% | -71.57% | -76.76% |